Alkermes Is A Global Biopharmaceutical Company Headquartered In Dublinirelandwith A Focus On Neurosciencefounded In 1987The Company Specializes In Developing Innovative Medicines For Serious Mental Illnessesaddictionand Cancerits Research And Development Facilities Are Located In Walthammassachusettsand Manufacturing Takes Place In Wilmingtonohioalkermes Employs Around 2 900 People Worldwide The Company Offers A Range Of Productsincluding Vivitrol For Alcohol Dependence And Opioid Relapse Preventionaristada For Schizophrenia Treatmentand Lybalvi For Schizophrenia And Bipolar Disorderalkermes Is Dedicated To Advancing Drug Delivery Technologies And Creating New Treatments For Complex Psychiatric And Neurological Disorderswith A Revenue Of $1 13 Billion In 2023Alkermes Continues To Invest Significantly In Research And Developmentreflecting Its Commitment To Innovation In The Biopharmaceutical Industrythe Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Alks
